Looking for more ways to get
involved and share OWL’s vision? Consider the benefits of an OWL
Looking for ways to
align with OWL and increase your company’s visibility?
Sign up for access to exclusive content, events, materials and updates from OWL.
Rarely will you find a value as great as an OWL membership! By becoming a member you establish yourself as committed to "Advancing Diversity in Leadership" and in standing as a leader for today's world. You'll also be affiliated with the best and brightest in Ophthalmology. Take a look here at some of our Champion members!LEARN MORE
OWL: Advancing Diversity in Leadership was established in the US in 2004 and up until this time has predominantly focused…
The Key Takeaways From Our Conversations with Ophthalmic World Leaders We had the honor to conduct nine interviews with OWL…
OWL: Advancing Diversity in Leadership is delighted to announce the “Bridging the ‘O’s” initiative, bringing together all eyecare by expanding…
Developing leaders is OWL's mission and our specialty! Get terrific experience and benefit from the best-of-the-best networking in Ophthalmology when you get involved in OWL:
OWL is a 501(c)3 organization, meaning any financial contribution is 100% tax-deductible. OWL focuses the investment of members’ dues on programs and events that will benefit members (our admin costs are low compared to other nonprofits).
Your company can align with OWL's mission by having a presence at our events and benefit from exposure on our social mediachannels and in our member communications. Organizations and companies that want to be involved at the highest level can enroll their associates as virtual members, receive educational programs and get sponsorship exposure by becoming an OWL Partner.LEARN MORE
The OWL Awards are given annually at OWL's Signature Event during AAO. The finalists are distinguished and respected - always an impressive group!
Nominations for the OWL Awards open in the Summer. A Nominations Committee selects the finalists and then OWL members cast their votes in the Fall.
Contact Us for information on nominating a colleague as a ‘Rising Star’, ‘Catalyst’ or ‘Visionary’ in Ophthalmology.LEARN MORE
Founder & CEO
Ocular Clinical Research Company
Physician, Ophthalmology Biopharmaceutical Executive Consultant, Clinical Development Career Coach & Mentor With over 22 years of proven success working in the Ophthalmology and Biopharma Industry, Dr. Ihekoromadu is leveraging the experience, knowledge, and established relationships to make a difference in the Ophthalmology Clinical research space.
Her dedication and passion for excellence led her to uncover the unmet talent training and recruitment needs in Ophthalmology Clinical development for Biopharma companies. As the Founder and CEO of Ocular Clinical Research Company (Ocular CRC), the fastest-growing Ophthalmology consulting firm, she is commited to improving the quality of Ophthalmology clinical trials by training and placing eye and vision care specialsts as Consultants in Clinical development and Drug safety jobs, to develop and medical monitor clinical trials for the treatment and prevention of eye diseases.
A strategic thinker with strong analytical skills, perseverance and drive, Dr. Ihekoromadu created a robust formal Ophthalmology Clinical development job training program, Ocular CRC College, with certification courses. With proven success in graduating doctors from the Ocular CRC College program and placing them in Clinical development positions with Biopharma companies as Ocular CRC Consultants, Dr. Nnenna is committed to the Ocular CRC mission of providing trusted medical experts for visionary excellence. She is the Principal Medical Consultant for different Ophthalmology sponsors, an executive coach and mentor for Ocular CRC College courses.
Dr. Nnenna found her niche in Ophthalmology Clinical development as a leader at Santen Pharmaceuticals and Syneos Health, where she interfaced with different regulatory authorities including the US FDA, and the Japanese PMDA. In her role as an executive consultant for Applied Genetic Technologies Corporation, she successfully led the Clinical Affairs, Medical Affairs, Drug Safety, Pharmacovigilance, Data Management and Biostatistics teams to advance the company’s Inherited Retinal Disorder programs.
Her career in Pharmaceuticals excelled tremendously through a unique combination of outstanding medical, scientific, business and leadership skills. She has successfully led multiple teams and programs for different top companies and launched multiple products like Topamax at Johnson & Johnson, Xibrom at ISTA Pharmaceuticals, and Besivance at Bausch & Lomb.
Dr. Ihekoromadu gained her Ophthalmology clinical experience from UCLA, Jules Stein Eye Institute, and her Medical Degree from University of Nigeria, Enugu Campus. Nnenna is mother of two college kids, and currently resides in Southlake, Texas.More OWL Champions
Adam Szaronos joined Trukera Medical in June 2020 to oversee the company’s global expansion efforts, and was later appointed to CEO of the organization in 2021. Adam has over 15 years of ophthalmic industry experience, where he and his teams have worked on 30+ new technology launches across areas of cataract, refractive, and vitreoretinal surgery, diagnostics, and digital health. Adam is most passionate about building and leading high impact teams focused on “white-space” new ventures and opportunities. Prior to Trukera Medical, Adam most recently served as the Head of Dry Eye Devices at Alcon, where he was responsible for launching and leading this new business unit for the organization. During his 13 years at Alcon, Adam held leadership roles in various sales, marketing, and strategy functions across their surgical and vision care businesses. Adam earned his M.B.A from MIT’s Sloan School of Management, with a focus on Innovation Leadership, and his B.S. from Indiana University’s Kelley School of Business, where he completed a double major in Marketing and Operations.More OWL Champions